Transcriptional profiling of human dendritic cell populations and models--unique profiles of in vitro dendritic cells

Kristina Lundberg1, Ann-Sofie Albrekt, Inge Nelissen

  • 1Department of Immunotechnology, Lund University, Lund, Sweden. kristina.lundberg@immun.lth.se

Plos One
|January 24, 2013
PubMed

Insights

In vitro dendritic cell (DC) models show unique transcriptional profiles, closely resembling specific myeloid DC subsets. This research aids in selecting appropriate DC models for immunotherapy and in vitro immune function assays.

Area of Science:

  • Immunology
  • Cell Biology
  • Transcriptomics

Background:

  • Dendritic cells (DCs) are key immune orchestrators, but their scarcity necessitates in vitro models for research and immunotherapy.
  • The relationship between existing in vitro DC models and primary DC populations is not well understood.

Purpose of the Study:

  • To characterize and evaluate the functionality and applicability of common in vitro dendritic cell (DC) models.
  • To compare in vitro DC models with primary DC populations using a genome-wide transcriptional analysis.

Main Methods:

  • Genome-wide transcriptional profiling was conducted on four in vitro DC models: MUTZ-3-DCs, monocyte-derived DCs, CD34-derived DCs, and Langerhans cells (LCs).
  • These models were compared to nine primary human DC populations, including various myeloid DC subsets from blood and tonsils.

Main Results:

  • Principal Component Analysis revealed that all in vitro DC models most closely resembled tonsillar myeloid DCs (mDCs), specifically CD1c(+) and CD141(+) subsets.
  • No single in vitro model demonstrated superior resemblance to all primary DC populations, suggesting a need for improved differentiation strategies.
  • Hierarchical clustering identified distinct gene expression patterns within both model and primary DCs, with model DCs expressing relevant immune transcripts.

Conclusions:

  • The distinct transcriptional profiles of in vitro DC models indicate varied functionalities for immune applications.
  • These findings will guide the selection of suitable DC models for in vitro assays and support the advancement of DC-based immunotherapy development.
Abstract

Related Concept Videos